securities fraud

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.

Law firm sues Quantum Biopharma for alleged market manipulation through spoofed sell orders, claiming defendants artificially suppressed stock price from 2021-2025.

Pomerantz Law Firm files class action against Quantum Biopharma, alleging Canadian banks used spoofed orders to artificially depress stock price and buy shares at reduced rates.

Schall Law Firm launches class action against Inovio Pharmaceuticals for alleged misrepresentations about manufacturing capabilities and regulatory timelines. Investors can join until April 7, 2026.

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities artificially inflated stock prices, harming shareholders during February-October 2025.

Ramaco Resources faces class action lawsuit for allegedly misrepresenting Brook Mine's operational status, failing to disclose lack of mining activity despite groundbreaking ceremony claims.

Class action lawsuit filed against Smart Digital Group for allegedly failing to disclose market manipulation and fraudulent promotional activities that harmed investors between May and September 2025.

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors who purchased shares between June 2023 and December 2025 may be eligible.

Class action lawsuit filed against Sallie Mae for allegedly concealing loan delinquency increases and overstating loss mitigation effectiveness, artificially inflating stock prices during July-August 2025.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating benefits of risk reduction initiatives, affecting investors from February-August 2025.

REGENXBIO faces class action lawsuit alleging false statements about RGX-111 gene therapy trial results, covering securities purchased between February 2022 and January 2026.

Klarna faces class action lawsuit alleging it misrepresented loan portfolio risks and understated credit exposure in its September 2025 IPO.

Schall Law Firm files securities fraud class action against Picard Medical for allegedly misleading investors through false statements and an alleged "pump and dump" scheme during September-October 2025.

BellRing Brands faces securities lawsuit over false statements. Lead plaintiff deadline is March 23, 2026 for eligible investors who suffered losses.

REGENXBIO faces class action lawsuit alleging securities violations over failure to disclose adverse information about RGX-111 before FDA clinical hold.

Schall Law Firm sues Ardent Health for securities fraud, alleging material misrepresentations about accounts receivable practices and insurance coverage between July 2024 and November 2025.

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

Schall Law Firm files class action against Charming Medical over SEC trading suspension, alleging securities fraud from coordinated social media promotion scheme driving suspicious stock spike.

KDDI faces securities investigation over delayed earnings disclosure and potential misleading business information. Stock fell 11.4% as Rosen Law Firm explores class action litigation for shareholders.